[
    [
        {
            "time": "",
            "original_text": "康泰生物(300601.SZ)子公司收到冻干人用狂犬病疫苗(人二倍体细胞)临床试验总结报告",
            "features": {
                "keywords": [
                    "康泰生物",
                    "子公司",
                    "冻干人用狂犬病疫苗",
                    "人二倍体细胞",
                    "临床试验",
                    "总结报告"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康泰生物(300601.SZ)子公司收到冻干人用狂犬病疫苗(人二倍体细胞)临床试验总结报告",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]